Drug Profile
AMG 853
Alternative Names: AMG-853Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Amgen
- Class Antiasthmatics; Small molecules
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 21 Apr 2011 Discontinued - Phase-I for Asthma in Australia (PO)
- 21 Apr 2011 Discontinued - Phase-II for Asthma in Canada (PO)
- 21 Apr 2011 Discontinued - Phase-II for Asthma in France (PO)